Curaleaf Holdings (CURLF) Shares Outstanding (Weighted Average) (2019 - 2026)

Curaleaf Holdings (CURLF) recorded quarterly Shares Outstanding (Weighted Average) of $90.0 in Q1 2026, down 100.0% quarter-over-quarter from $762.1 million in Q4 2025, and down 100.0% on a YoY basis from $744.9 million in Q1 2025.

Curaleaf Holdings (CURLF) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

Curaleaf Holdings' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $90.0 for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) fell 100.0% year-over-year to $90.0; the TTM figure through Mar 2026 stood at $90.0 (down 100.0% YoY), while the FY2025 annual figure was $762.1 million, up 2.87% from the prior year.
  • Shares Outstanding (Weighted Average) was $90.0 for Q1 2026 at Curaleaf Holdings, down from $762.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $762.1 million in Q4 2025 to a low of $90.0 in Q1 2026.
  • Historically, Shares Outstanding (Weighted Average) has averaged $680.1 million across 5 years, with a median of $730.7 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) climbed 3.94% in 2022, then sank 100.0% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $709.6 million in 2022, then rose by 2.04% to $724.1 million in 2023, then increased by 2.31% to $740.8 million in 2024, then gained by 2.87% to $762.1 million in 2025, then plunged by 100.0% to $90.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $90.0 (Q1 2026), $762.1 million (Q4 2025), and $757.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Curaleaf Holdings - - 157.29 Mn 90.00

Historic Data

Download Data
DateValue
Mar 31, 2026 90.00
Dec 31, 2025 762.09 Mn
Jun 30, 2025 757.27 Mn
Mar 31, 2025 744.90 Mn
Dec 31, 2024 740.83 Mn
Sep 30, 2024 742.54 Mn
Jun 30, 2024 740.79 Mn
Mar 31, 2024 736.15 Mn
Dec 31, 2023 724.12 Mn
Sep 30, 2023 725.32 Mn
Jun 30, 2023 719.27 Mn
Sep 30, 2022 709.64 Mn
Jun 30, 2022 709.97 Mn
Mar 31, 2022 708.90 Mn
Dec 31, 2021 2.23 Bn
Sep 30, 2021 703.55 Mn
Jun 30, 2021 701.67 Mn
Mar 31, 2021 682.04 Mn
Dec 31, 2020 1.75 Bn
Sep 30, 2020 1.73 Bn